Quest Diagnostics Minimizes China Tariff Risk With Less Than 1% Supply Chain Exposure

Company Leans On Domestic Sourcing And Long-Term Contracts To Shield Operations From Trade Disruption.

Tariffs did not prevent Quest from reporting strong margin performance in the first quarter. (Shutterstock)

More from Strategy

More from Medtech Insight